(Q44168742)

30 November 2017

Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV). (English)

1 reference

30 November 2017

S Wrenger

1

1 reference

30 November 2017

T Kähne

2

1 reference

30 November 2017

C Bohuon

3

1 reference

30 November 2017

W Weglöhner

4

1 reference

30 November 2017

S Ansorge

5

1 reference

30 November 2017

D Reinhold

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

30 November 2017

1 reference

30 November 2017

466

1 reference

30 November 2017

1

1 reference

30 November 2017

155-159

1 reference

Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

Procalcitonin--a new indicator of the systemic response to severe infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

Proline-dependent structural and biological properties of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

CD26: a surface protease involved in T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

CD26, let it cut or cut it down.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

Measurement of Procalcitonin Levels in Children with Bacterial or Viral Meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

High serum procalcitonin concentrations in patients with sepsis and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

Procalcitonin in patients with and without immunosuppression and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

Engineering Escherichia coli to secrete heterologous gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

Dipeptidyl Peptidase IV in the Immune System. Effects of Specific Enzyme Inhibitors on Activity of Dipeptidyl Peptidase IV and Proliferation of Human Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2901779-2

10.1016/S0014-5793(99)01779-2

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference